SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation

被引:119
作者
Tannahill, GM
Elliott, J
Barry, AC
Hibbert, L
Cacalano, NA
Johnston, JA
机构
[1] Queens Univ Belfast, Infect & Immun Grp, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland
[2] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
[3] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Radiat Oncol, Los Angeles, CA 90095 USA
关键词
D O I
10.1128/MCB.25.20.9115-9126.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytokine responses can be regulated by a family of proteins termed suppressors of cytokine signaling (SOCS) which can inhibit the JAK/STAT pathway in a classical negative-feedback manner. While the SOCS are thought to target signaling intermediates for degradation, relatively little is known about how their turnover is regulated. Unlike other SOCS family members, we find that SOCS2 can enhance interleukin-2 (IL-2)- and IL-3-induced STAT phosphorylation following and potentiate proliferation in response to cytokine stimulation. As a clear mechanism for these effects, we demonstrate that expression of SOCS2 results in marked proteasome-dependent reduction of SOCS3 and SOCS1 protein expression. Furthermore, we provide evidence that this degradation is dependent on the presence of an intact SOCS box and that the loss of SOCS3 is enhanced by coexpression of elongin B/C. This suggests that SOCS2 can bind to SOCS3 and elongin B/C to form an E3 ligase complex resulting in the degradation of SOCS3. Therefore, SOCS2 can enhance cytokine responses by accelerating proteasome-dependent turnover of SOCS3, suggesting a mechanism for the gigantism observed in SOCS2 transgenic mice.
引用
收藏
页码:9115 / 9126
页数:12
相关论文
共 44 条
[1]   The inducible elongin A elongation activation domain: Structure, function and interaction with the elongin BC complex [J].
Aso, T ;
Haque, D ;
Barstead, RJ ;
Conaway, RC ;
Conaway, JW .
EMBO JOURNAL, 1996, 15 (20) :5557-5566
[2]   Pim serine/threonine kinases regulate the stability of Socs-1 protein [J].
Chen, XP ;
Losman, JA ;
Cowan, S ;
Donahue, E ;
Fay, S ;
Vuong, BQ ;
Nawijn, MC ;
Capece, D ;
Cohan, VL ;
Rothman, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2175-2180
[3]  
Cohney SJ, 1999, MOL CELL BIOL, V19, P4980
[4]   Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation [J].
De Sepulveda, P ;
Ilangumaran, S ;
Rottapel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14005-14008
[5]   Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor [J].
Dif, F ;
Saunier, E ;
Demeneix, B ;
Kelly, PA ;
Edery, M .
ENDOCRINOLOGY, 2001, 142 (12) :5286-5293
[6]   SOCS: role in inflammation, allergy and homeostasis [J].
Elliott, J ;
Johnston, JA .
TRENDS IN IMMUNOLOGY, 2004, 25 (08) :434-440
[7]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[8]   Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction [J].
Favre, H ;
Benhamou, A ;
Finidori, J ;
Kelly, PA ;
Edery, M .
FEBS LETTERS, 1999, 453 (1-2) :63-66
[9]   Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation [J].
Frantsve, J ;
Schwaller, J ;
Sternberg, DW ;
Kutok, J ;
Gilliland, DG .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (10) :3547-3557
[10]   Regulation of cytokine signaling by SOCS family molecules [J].
Fujimoto, M ;
Naka, T .
TRENDS IN IMMUNOLOGY, 2003, 24 (12) :659-666